TABLE 1.
Virus | Relative Infectivity (%) to WT HIV |
|||
---|---|---|---|---|
Jurkat E6-1 | HSP90AB1 | Fold- Increase |
Hsp90AB1 E42A+D88A |
|
Wild-Type HIV | 100 | 133 ± 11 | 1.3 | 83 ± 7 |
HIV PRI54V+V82A | 15 ± 4 | 69 ± 3 | 4.6 | 17 ± 4 |
HIV CAP38A | 6 ± 1 | 20 ± 4 | 3.4 | 8 ± 1 |
HIV CAE45A | 5 ± 1 | 22 ± 2 | 4.4 | 6 ± 1 |
HIV CAQ63A+Q67A | 5 ± 1 | 23 ± 6 | 4.6 | 5 ± 1 |
HIV CAE128A+R132A | 22 ± 3 | 38 ± 3 | 1.7 | 34 ± 4 |
HIV CAN139A | 15 ± 1 | 81 ± 8 | 5.4 | 15 ± 1 |
HIV CAR143A | 17 ± 1 | 37 ± 3 | 2.1 | 13 ± 1 |
Relative infectivity of WT and mutant HIV in Jurkat E6-1/HSP90AB1 and Jurkat E6-1/HSP90AB1E42A+D88A cells compared to WT HIV infectivity in Jurkat E6-1 cells after 12 days of continuous culture. Results are expressed as mean infectivity ± S.E. for three independent transduction experiments each performed in triplicate.